ACET
Adicet Bio, Inc.
Key Financials
Net Income
$-116803000
↑ 0.3%
Operating Income
$-122114000
↑ 4.3%
Total Assets
$192.4M
↓ 12.7%
Shareholders' Equity
$159.2M
↓ 14.7%
EPS (Diluted)
$-16.95
↓ 1174.4%
Cash & Equivalents
$38.9M
↓ 31.1%
Total Liabilities
$33.1M
↓ 1.4%
Operating Cash Flow
$-95246000.00
↓ 3.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACET |
| Company Name | Adicet Bio, Inc. |
| CIK | 1720580 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1226 |
| State of Incorporation | DE |
| Phone | 617-482-2333 |